The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $119.16

Today's change-0.28 -0.23%
Updated August 24 1:15 PM EDT. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $119.16

Today's change-0.28 -0.23%
Updated August 24 1:15 PM EDT. Delayed by at least 15 minutes.

Johnson & Johnson down (U.S.)$0.28

Johnson & Johnson is lower today, dropping (U.S.)$0.28 or 0.23% to (U.S.)$119.16. Shares have lost 1.77% over the last five days, but have gained 16.01% over the last year to date. This security has outperformed the S&P 500 by 13.03% during the last year.

Key company metrics

  • Open(U.S.) $119.48
  • Previous close(U.S.) $119.44
  • High(U.S.) $119.61
  • Low(U.S.) $118.85
  • Bid / Ask(U.S.) $119.16 / (U.S.) $119.17
  • YTD % change+16.01%
  • Volume2,238,453
  • Average volume (10-day)6,949,604
  • Average volume (1-month)6,222,096
  • Average volume (3-month)6,893,997
  • 52-week range(U.S.) $118.85 to (U.S.) $126.07
  • Beta0.62
  • Trailing P/E22.20×
  • P/E 1 year forward17.85×
  • Forward PEG2.72×
  • Indicated annual dividend(U.S.) $3.20
  • Dividend yield2.69%
  • Trailing EPS(U.S.) $5.37
Updated August 24 1:15 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.41%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 03, 201607/03/2016Apr 03, 201604/03/2016Jan 03, 201601/03/2016Sep 27, 201509/27/2015
Revenue18,48217,48217,81117,102
Total other revenue--------
Total revenue18,48217,48217,81117,102
Gross profit13,15312,17012,13811,878
Total cost of revenue5,3295,3125,6735,224
Total operating expense13,57812,18814,05312,980
Selling / general / administrative5,1764,6885,8915,081
Research & development2,2642,0132,8642,154
Depreciation / amortization--------
Interest expense (income), net operating190160160123
Unusual expense (income)15013772310
Other operating expenses, total593-37-1,205412
Operating income4,9045,2943,7584,122
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax4,9045,2943,7584,122
Income after tax3,9974,4573,2153,358
Income tax, total907837543764
Net income3,9974,4573,2153,358
Total adjustments to net income--------
Net income before extra. items3,9974,4573,2153,358
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,9974,4573,2153,358
Inc. avail. to common incl. extra. items3,9974,4573,2153,358
Diluted net income3,9974,4573,2153,358
Dilution adjustment------0
Diluted weighted average shares2,7942,7982,8002,807
Diluted EPS excluding extraordinary itemsvalue per share1.431.591.151.20
Dividends per sharevalue per share0.800.750.750.75
Diluted normalized EPSvalue per share1.431.601.571.20